November 5th | Regulation and Trustworthiness of Politicized Science
Art Reingold, MD
In early spring, over 100 vaccines began their journey through development and testing. The severity and magnitude of the global COVID-19 pandemic catalyzed an unprecedented race of innovation to develop novel vaccines with the goal of suppressing a growing public health crisis. As summer turns into fall, top candidates have entered phase 3 clinical trial testing. This race is not purely scientific, but also political. Recent decisions by the FDA, CDC, and other government agencies have raised concerns about veiled interests and hasty decisions. As the public looks for objective decision-making and clear communication, trustworthiness continues to degrade leaving people skeptical of quickly advancing vaccine developments. How can we ensure that those in charge of regulating data and deliverables remain shielded from politicization and reestablish trustworthiness?